학술논문

CheMo4METPANC: Combination Chemotherapy ( gemcitabine and nabpaclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in METastatic treatment-naive PANCreatic adenocarcinoma
Document Type
Journal
Source
CANCER RESEARCH; JAN 15 2024, 84 2, 2p. Supplement: S
Subject
Language
English
ISSN
15387445